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INTRODUCTION
There is increasing evidence that cancer 
survival can sometimes be improved by 
earlier diagnosis, which is potentially 
achievable through symptomatic individuals 
presenting earlier to health professionals.1 
This is true for a number of cancers including 
most of the gynaecological cancers, which 
have a combined annual incidence second 
only to breast cancer in the UK (n = 19 631, in 
2010).2–5 Thomson and Forman6 concluded 
that earlier diagnosis of cervical and uterine 
cancers could reduce the survival gap 
between England and European averages, 
and differences in ovarian cancer survival 
could also be reduced by earlier diagnosis, 
although care factors after diagnosis also 
play a role.
Encouraging earlier presentation of 
cancer symptoms could be achieved 
in a variety of ways, including education 
and information provision (for example, 
multimedia campaigns) as well as changes 
in healthcare provision (for example, 
access to appointments). In the UK there 
has been a coordinated effort between 
the Department of Health and cancer 
charities to develop programmes of cancer 
awareness-raising activities through the 
National Awareness and Early Diagnosis 
Initiative (NAEDI). Increasing public cancer 
awareness via information provision is a key 
strategy for increasing the rates of earlier 
presentation.7 The assumption is that 
education leads to symptom awareness, 
which is a necessary prerequisite to help-
seeking behaviour. There is some evidence 
from evaluation data assessing the impact 
of UK multimedia cancer awareness 
campaigns that supports this assumption.8,9 
Changes in behaviour, such as increased 
presentations to the GP8,9 and attendance 
at cancer screening,10 have been recorded 
and associated with an increase in urgent 
referrals for investigations.8 Evidence that 
more cancers are being detected, and 
at an earlier stage, is preliminary. In one 
encouraging example, a regional evaluation 
of a lung cancer awareness campaign found 
a significant increase in the number of small 
cell cancers staged as ‘limited’ (that is, 
confined to one lung and relatively early in 
presentation).8
Some clinicians have been critical of efforts 
to educate the public about cancer symptoms 
as a means of promoting early detection. 
The impact of education has been labelled 
by some as ‘the curse of awareness’,11 with 
concerns voiced that campaigns may lead 
patients to have an exaggerated perception 
of personal risk and increased anxiety about 
their health. This may lead to the ‘worried 
well’ flooding general practice, resulting 
in unnecessary investigations to reassure 
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Abstract
Background
In the UK there has been an effort, through the 
National Awareness and Early Diagnosis Initiative 
(NAEDI), to increase early stage diagnoses and 
ultimately cancer survival. Encouraging early 
symptom presentation through awareness-
raising activities in primary care is one method 
to achieve this goal. Understanding GPs’ views 
about this type of activity, however, is crucial prior 
to implementation.
Aim
To describe GPs’ attitudes to raising public 
awareness of gynaecological cancers, and their 
views about the potential impact on primary 
care services.
Design and setting
An online survey with a convenience sample 
recruited from 1860 UK general practices.
Method
An invitation was emailed to GPs via practice 
managers and included a weblink to a draft 
education leaflet and an online survey about the 
impact of sending a leaflet giving information 
about symptoms associated with gynaecological 
cancers to all women on GPs’ lists. Participants 
could offer additional free text comments which 
were coded using content analysis.
Results
A total of 621 GPs participated. Most (77%, 
477) felt that raising awareness of cancers was 
important. Only half (50%, 308), however, indicated 
that they would distribute such a leaflet from their 
practice. Barriers to implementation included 
concerns about financial costs; emotional impact 
on patients; increased demand for appointments 
and diagnostic services, such as ultrasound.
Conclusions
GPs were generally positive about an 
intervention to improve patients’ awareness 
of gynaecological cancers, but had concerns 
about increasing rates of presentation. There is 
a need for research quantifying the benefits of 
earlier diagnosis against resource costs such 
as increased consultations, investigations, and 
referrals.
Keywords
early detection of cancer; general practice; 
patient education, primary health care.
e372  British Journal of General Practice, June 2014
patients that they do not have cancer.12 
There have been no systematic attempts 
to quantify the extent of GPs’ concerns, 
although GPs are recognised as influential 
in raising the profile of cancer symptoms 
among their patients.7 As gatekeepers to 
secondary care and diagnostic services, 
GPs are key stakeholders in developing 
educational initiatives designed to increase 
help-seeking behaviour. GPs’ concerns 
regarding these initiatives, therefore, must 
be identified and dealt with.
In this study, a leaflet was developed 
to encourage the earlier presentation 
of women with gynaecological cancer 
symptoms. The leaflet, to be directly mailed 
to women aged ≥40 years on GPs’ lists 
contained information about gynaecological 
cancers including symptoms and signs, 
a symptom checklist for patients to 
complete and take to a GP appointment, 
and acknowledged common help-seeking 
barriers and suggestions of how to 
overcome these. In addition, one panel of 
the leaflet included a ‘letter’ from the GP 
inviting women to make an appointment if 
they had any of the symptoms highlighted 
in the leaflet. Leaflets are a commonly used 
and relatively inexpensive, but pragmatic 
approach to imparting health information. 
They can be used as a stand-alone 
intervention or embedded within a more 
extensive multimedia social marketing 
campaign.13
To assess GPs’ attitudes to raising public 
awareness of gynaecological cancers and 
their views about the impact on primary 
care services, a sample of GPs were invited 
to comment on a draft version of the leaflet 
and to give their views about the likely effect 
of distributing it.
METHOD
This web-based survey was delivered to a 
convenience sample of GPs. The design was 
categorised as service evaluation.
In October 2011 an email was sent to 
1860 practice managers in the UK via the 
following organisations: the Primary Care 
Research Network (PCRN), the General 
Practice Research Framework (GPRF), 
and the Society for Academic Primary Care 
(SAPC). The 1860 practices represented 
approximately 20% of registered general 
practices within the UK (excluding Northern 
Ireland).14
Practice managers were asked to forward 
the email to all doctors (including locums 
and trainees) working in their surgery. The 
email gave details of the study, a weblink 
to the leaflet and to a short (approximately 
15-minute) questionnaire. A small incentive 
was offered, with a prize draw giving the 
opportunity to win £75 in vouchers or 
six bottles of sparkling wine being held 
3 months after the initial email. 
Participation was anonymous, and 
informed consent was assumed if 
responders proceeded to the questionnaire. 
Two reminders to participate were sent to 
practice managers at 3–4-week intervals. 
The website was live between November 
2011 and January 2012.
Measures
The survey was developed in collaboration 
with the GP researchers in this study, before 
being piloted with two further independent 
GPs. There was a mixture of closed and 
open-response (free text) questions. The 
questionnaire and items included in the 
analysis are available from the authors 
on request. The questions included were 
broadly categorised into three themes.
Exploring perceived need for, and 
commitment to, raising awareness 
of gynaecological cancer symptoms. 
Participants were asked what they thought 
could prevent women from presenting 
early with symptoms of gynaecological 
cancers and what suggestions they had for 
overcoming these barriers. Commitment 
to raising awareness was assessed using 
responses to two statements using a 5-point 
agreement scale: ‘Personally I think that 
raising awareness of the symptoms of 
gynaecological cancers is a high priority’, 
and ‘I expect that sending out this leaflet to 
women in my practice would be considered 
a priority by the practice team’. The 5-point 
scale was later categorised into three: 
‘strongly disagree/disagree’, ‘unsure’, and 
‘agree/strongly agree’. Responders were 
also asked whether they had systems in 
place to encourage women with possible 
How this fits in
Raising cancer awareness among the 
public is a recent UK government strategy 
to encourage symptomatic patients to 
present promptly in primary care. This 
study highlights the role of GPs as key 
stakeholders in individualised interventions 
located within primary care, and reports 
the findings of a GP consultation at the 
development stage of a leaflet intervention 
aimed at increasing awareness of 
gynaecological cancers. The focus of this 
study was to identify and quantify levels of 
support and barriers to the implementation 
of such an intervention among GPs.
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gynaecological cancer symptoms to present 
at their practice with response options of: 
‘yes’, ‘no’, or ‘don’t know’.
Support for the leaflet and barriers to 
implementation. Responders were asked 
to indicate whether they would agree, in 
principle, to send the leaflet from their 
practice (‘yes’, ‘no’, and ‘maybe’), and about 
the possible impact of doing this by rating 
their agreement with nine statements (on 
the same agreement scale as above, later 
collapsed into three), for example ‘I expect 
that sending out this leaflet to women in my 
practice would be time consuming’.
Responders were asked about the 
local availability of diagnostic services 
for gynaecological cancers and to 
indicate whether diagnostic testing was 
available in-house (‘yes’ or ‘no’). Finally, 
responders rated ease of access for each 
of these investigations: CA125 serum 
test, abdominal ultrasound, transvaginal 
ultrasound, and colposcopy.
Practice and GP characteristics. 
Participants provided demographic details 
about themselves and their practice 
including: responder age, sex, and ethnicity, 
practice list size, location (region within the 
UK as well as practice setting: whether it 
was ‘urban’, ‘suburban’, ‘rural’, or ‘none of 
these’), ethnic diversity of the patient list, 
and whether there was a gynaecological 
specialist at the practice. For the analyses, 
ethnic diversity of the patient list was 
collapsed from four categories (‘very mixed 
across ethnicities’, ‘a mix of two main 
ethnicities’, ‘a majority of one ethnicity’, and 
‘almost exclusively one ethnicity’) into two 
categories: ‘mixed ethnicities’ and ‘majority 
of one’; and GP ethnicity was collapsed into 
two categories: ‘white’ and ‘not white’.
Analysis
Content analysis15 was used to convert 
free text comments into numerical data 
that could be summarised alongside the 
quantitative responses. Data were analysed 
using IBM SPSS (version 20). Proportions 
and frequencies were calculated and group 
differences were tested using χ2 analyses 
and ANOVA. Quotes from the free text 
comments illustrate findings described in 
the results.
For the content analysis, a coding 
framework was developed to describe 
free text responses in terms of the range 
of beliefs expressed, and the numerical 
frequency with which they occurred. A 
belief was defined as a specific idea, and 
could be a single word or several sentences 
of text coded for manifest meaning. Beliefs 
for each question were coded separately 
and recorded only once per participant per 
question. The framework was developed 
by two researchers using a thematic 
approach.16 A cyclical process of coder 
training, testing, and revision was followed 
to refine the categories and codes. Inter-
rater reliability was calculated (IRR; 
Cohen’s k) based on data from 10% of the 
sample (n = 60). All the k values were within 
the acceptable range (all >0.8, P<0.001 
with the exception of one, ‘suggestions 
for overcoming barriers’ which was 0.7, 
P<0.001).17 The remaining data were then 
coded using NVivo 9. After coding it was 
possible to produce numerical tables 
where columns represented beliefs and 
rows represented participants. Each cell 
contained either a 0 or 1 to represent 
absence or presence of a belief. 
RESULTS
A total of 621 GPs responded. The 
response rate could not be calculated as 
the numbers of GPs recruited and working 
at each practice could not be identified. 
Most responders worked in England 
(99%, Table 1). Comparison with statistics 
for England18 suggests the sample over-
represented the 40–49 years age range 
(37% versus 32% nationally), and that there 
was a greater proportion of female GPs 
in the sample than would be expected 
(58% versus 46%), although retainers and 
registrars were not included in the national 
figures. The mean list size in the sample 
(10 039) was bigger than the national 
average of 6651. This may reflect the 
larger representation of practices from the 
Midlands and Eastern England where there 
are typically larger practice sizes.
Exploring the need and support for 
raising awareness of gynaecological 
cancer symptoms
Reasons for longer time to presentation. 
Most GPs (86%, 532/621) offered at least 
one reason for late presentation among 
women with gynaecological cancer 
symptoms (Table 2). Only a few (2%, 14/621) 
reported that women attended promptly 
with such symptoms. The most often cited 
cause of longer time to presentation was 
low awareness (43%, 267/621) resulting 
in patients failing to understand the 
significance of symptoms. The vague 
nature of many of the symptoms associated 
with gynaecological cancers, particularly 
ovarian cancer, was highlighted as a key 
cause of longer time to presentation (20%, 
124/621), for example:
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‘[symptoms] … are very non-specific and 
confused with events such as menopause, 
gaining weight or [confused with] GI 
symptoms.’ (#433) 
Another often cited barrier was patients’ 
embarrassment (32%, 199/621), including 
embarrassment about the urogenital area, 
symptoms potentially related to sex (for 
example, postcoital bleeding), and the 
possibility of discussing symptoms with a 
male GP. Other emotional barriers identified 
by GPs included fear, anxiety, and stigma 
associated with a cancer diagnosis (19%, 
116/621). These barriers were thought to 
lead to denial and ultimately a longer time 
to presentation, for example:
‘They may fear cancer so bury their head in 
the sand and avoid the GP.’ (#507)
Suggestions for improving early 
presentation. Most GPs (70%, 433/621) 
offered ideas about how to improve 
early presentation. The most common 
suggestion was patient education (51%, 
316/621), through national media and local 
community campaigns, practice specific 
initiatives, or opportunistic conversations 
with patients. Other suggested solutions 
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Table 1. Demographics of participants and their practicesa
GP characteristics (n = 621) % (n)
Age, years  
  <30 1.6 (10) 
  30–39 19.8 (123) 
  40–49 37.4 (232) 
  50–59 35.3 (219) 
  60–69 4.2(26) 
  ≥70 0.2 (1)
Sex 
  Male 41.1 (255) 
  Female 58.3 (362)
Ethnicity  
  White 85.7 (532) 
  Black/African/Caribbean/black British 1.1 (7) 
  Asian/Asian British 9.3 (58) 
  Mixed/ other 2.3 (14)
Practice characteristics (n = 621, some participants may have come from same practice)
List size mean 10 039.86b (SD 7812.1) 
  Smaller than national average ≤6651 29.8 (185) 
  Larger than national average ≥6652 68.6 (426)
Location of GP practice 
  East England 16.4 (102) 
  London and South East 18.9 (117) 
  Midlands 22.8 (141) 
  North East 3.4 (21) 
  North West 2.7 (17) 
  South West 16.6 (103) 
  York and Humber 15.3 (95) 
  Scotland 0.8 (5) 
  Wales 0.2 (1)
Practice setting 
  Urban 36.6 (227) 
  Suburban 36.6 (227) 
  Rural 20.6 (128) 
  None of these 5.8 (36)
Ethnicity diversity of patient list  
  Mixed 21.4 (133) 
  A majority of one  78.1 (485)
Gynaecological/women’s health specialist in practice  
  Yes  50.1 (311) 
  No or don’t know 49.4 (307)
aNumbers may not add up to 621 because of missing data; bMedian for the sample is n = 9000.
included improved healthcare provision 
(14%, 90/621), such as increasing access 
to appointments and to female doctors, as 
well as encouraging all staff to be more 
approachable, for example:
‘Good general practice and approachable 
primary care (includes GPs, nurses, 
receptionists etc).’ (#213)
Health professional training (3%, 16/621) 
was suggested by a few as a way to:
‘Ensure all GPs are aware of ALL symptoms 
and keep up-to-date with protocols and 
pathways.’ (#280) 
Overall, 106 GPs (17%) specifically cited the 
educational leaflet as a useful intervention: 
‘I think leaflets such as this can convince 
them [women] of the importance of 
presenting.’ (#199) 
One-quarter of responders (25%, 152/621) 
reported that they already had systems in 
place to encourage women with possible 
gynaecological cancer symptoms to present 
promptly at their practice, for example:
‘Posters in waiting room. Give health 
promotion and advice at contraceptive and 
smear appointments.’ (#722)
Levels of commitment to raising awareness 
and support for using the gynaecological 
cancers information leaflet. Most GPs (77%, 
477/621) believed that raising awareness 
of gynaecological cancers was a priority 
in general terms. For their own practice, 
however, most were more cautious and 
only 16% (100/621) agreed that raising 
awareness would be a priority for them. 
Half the sample (50%, 308/621) agreed, 
in principle, that they would send out 
the research leaflet from their practice. 
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Table 2. Reasons offered by GPs, in free text, for late presentation 
of potential gynaecological cancer symptoms listed in rank order  
(n = 621)
Barrier % sample (n)
Gynaecological cancer awareness 43.0 (267)
Embarrassment 32.0 (199)
How cancer symptoms present 20.0 (124)
Fear/anxiety/stigma of cancer 18.7 (116) 
Reluctance to engage with health professional/ health not prioritised  12.7 (79)
Access to health care 11.4 (71)
Socioeconomic factors (for example, education/ culture) 5.2 (32)
Reluctance to have an examination 4.7 (29)
Denial 3.7 (23)
False reassurance from a clear smear result 1.9 (12)
Perceive self to be low risk 1.1 (7)
Wait and see approach to symptoms 0.8 (5)
Fatalism 0.5 (3)
Acceptance of pain 0.3 (2)
Participants who did not offer an answer 9.8 (61)
Many participants cited more than one barrier so percentages do not add up to 100. 
Table 3. Overall perceived impact of the leaflet on patients and grouped by GPs’ inclination to use the 
leaflet (n = 621) 
  Group differences 
 GPs’ inclination to use the leaflet % (n) between proportions agreeing 
 Yes Maybe No χ2 (df) P-value
Would inform women about how to deal with symptoms they may have 
  Agree 84.0 (258) 62.9 (144) 43.4 (33) 
  Unsure 9.8 (30) 19.7 (45) 21.1 (16) 68.8 (4) <0.0001 
  Disagree 6.2 (19) 17.5 (40) 35.5 (27)
Has an appropriate level of encouragement 
  Agree 83.4 (256) 53.8 (121) 26.3 (20) 
  Unsure 12.1(37) 28.9 (65) 23.7 (18) 142.4 (4) <0.0001 
  Disagree 4.6 (14) 17.3 (39) 50.0 (38)
Would help patients talk about a difficult subject 
  Agree 91.9 (283) 69.0 (158) 52.6 (40) 
  Unsure 7.1 (22) 26.6 (61) 30.3 (23) 90.9 (4) <0.0001 
  Disagree 1.0 (3) 4.4 (10) 17.1 (13) 
Would increase women’s fears of gynaecological cancer    
  Agree 53.7 (165) 76.0 (174) 78.9 (60) 
  Unsure 28.0 (86) 14.8 (34) 14.5 (11) 36.1 (4) <0.0001 
  Disagree 18.2 (56) 9.2 (21) 6.6 (5)
df = degrees of freedom.
A minority (12%, 77/621) said they would 
not use the leaflet, and around one-third 
(37%, 229/621) were undecided (‘maybe’). 
Endorsement was not related to GP 
characteristics of sex (χ2 (2 degrees of 
freedom [df]) = 2.96, P = 0.228), age (F 
(2 df) = 2.697, P = 0.068), or ethnicity (χ2 
(2df) = 0.274, P = 0.874), nor to practice 
characteristics of practice setting (χ2 (4 df) 
= 2.94, P = 0.568), ethnic diversity of patients 
(χ2 (2 df) = 1.092, P = 0.579), or practice 
size (χ2 (2 df) = 1.611, P = 0.447). GPs who 
reported having a gynaecological specialist 
in the practice, however, were more likely to 
agree to send out the leaflet than those from 
practices with no gynaecological specialist 
(55% versus 45%; χ2 (2 df) = 6.133, P = 0.047).
As shown in Table 3, a greater proportion 
of GPs who said they would send out the 
leaflet thought that it would impact positively 
on women.
Barriers to using the gynaecological 
cancers information leaflet
One-third (36%, 224/621) of responders gave 
one or more free text comments in response 
to questions about whether they were 
prepared to distribute the leaflet, and their 
perceived barriers to its implementation 
are grouped by theme below. There were 
637 comments in total. A few (7%, 42/637) 
were positive endorsements or support for 
this intervention, whereas about half (46%, 
295/637) described the perceived potential 
negative impact of the leaflet on patients 
or practices. The remainder referred 
specifically to the content (13%, 84/637) and 
suggestions for change to either the leaflet 
or how it was disseminated (22%, 138/637).
A few GPs felt that they needed additional 
information (4%, 25/621) before making 
a decision about the leaflet. Although for 
some this was about seeking the opinions of 
colleagues, for others it was about needing 
to know the likely impact, for example:
‘I would want to see some evidence that 
there is a benefit, preferably from a good 
quality RCT showing that the leaflet actually 
results in a benefit (gynaecological cancers 
diagnosed sooner with corresponding 
clinical benefit) greater than the harms 
(costs, unnecessary investigations and 
consequences of that, stress to women).’ 
(#213)
Financial concerns. As reported in Table 4, 
over half the GPs agreed that it would be 
easy to mail out the leaflet (56%, 350/621), 
but most thought it would be costly (72%, 
445/621). 
Alternatives to a mail out were suggested 
and these included: having the leaflets 
available in the practice to pick up, displaying 
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Table 4. Perceived impact of the leaflet on GP practices with a total score and grouped by GP’s inclination 
to use the leaflet (n = 621) 
  Group differences 
 GPs’ inclination to use the leaflet % (n) between proportions agreeing 
Sending the leaflet would be … Yes Maybe No χ2 (df) P-value
… easy 
  Agree 70.1 (213) 46.9 (107) 36.8 (28)  
  Unsure 15.8 (48) 23.7 (54) 10.5 (8) 65.5 (4) <0.0001 
  Disagree 14.1 (43) 29.4 (67) 52.6 (40)
… time consuming 
  Agree 70.0 (212) 79.9 (183) 87.0 (67) 
  Unsure 10.9 (33) 8.3 (19) 6.5 (5)  13.7 (4) 0.0080 
  Disagree 19.1 (58) 11.8 (27) 6.5 (5)
… onerous on staff 
  Agree 56.0 (169) 73.4 (168) 77.6 (59) 
  Unsure 20.5 (62) 13.1 (30) 10.5 (8) 23.4 (4) <0.0001 
  Disagree 23.5 (71) 13.5 (31) 11.8 (9)
… unlikely to lead to many additional appointments    
  Agree 8.5 (26) 11.4 (26) 15.6 (12) 
  Unsure 20.3 (62) 11.4 (26) 11.7 (9) 11.5 (4) 0.0220 
  Disagree 71.1 (217) 77.3 (117) 72.7 (56)
… costly 
  Agree 68.6 (208) 78.4 (178) 76.3 (58) 
  Unsure 19.8 (60) 14.5 (33) 14.5 (11) 7.0 (4) 0.1350 
  Disagree 11.6 (35) 7.0 (16) 9.2 (7)
df = degrees of freedom.
the information as a poster, sending 
the leaflet with other correspondence, 
distributing leaflets electronically, or posting 
the leaflet on the practice website.
Impact on patient behaviour. About two-
thirds of the GPs (65%, 404/621) believed 
that the leaflet could increase patients’ 
fear of gynaecological cancers, and three-
quarters (450/621) felt that it would lead 
to a significant increase in the number of 
appointments made (Tables 3 and 4), at a 
time when resources were already tight and 
there was pressure to reduce budgets. One 
responder noted that: 
‘None of us are looking for extra work 
and this represents one of many invitations 
from different interest groups asking people 
to make appointments which are already 
difficult enough to obtain’ (#303)
Impact on diagnostic services. Most (85%, 
527/621) said that they felt that their current 
access to diagnostic services locally was 
‘just about right’ or ‘more than enough’ 
to meet demand. Similarly, most felt 
that access to specific investigations was 
‘extremely’ or ‘quite’ easy. Just under half 
of the responders reported that they could 
carry out diagnostic testing within their 
practice (43%, 267/621). Free text comments 
revealed that some GPs (9%, 53/621) were 
concerned about waiting times, particularly 
for non-urgent ultrasounds, where clinical 
presentation does not warrant referral via 
the 2-week wait rule:
‘Ease of access: we just have to write a 
request and wait. Speed of access: that’s 
a different and rather more pertinent 
question.’ (#218)
Only a few GPs (3%, 17/621) felt that 
secondary services would be unable to cope 
with any increase in demand, leaving patients 
alerted to the possibility of a problem but 
having to wait significant lengths of time 
before accessing diagnostic services. As a 
result, some felt that resources should be 
directed to diagnostic services rather than 
raising awareness: 
‘I think it is almost more important to provide 
the imaging services so that when GPs are 
concerned they can send the patients for 
hopefully a reassuring ultrasound within a 
week or two.’ (#211)
DISCUSSION
Summary
Despite general support for raising 
awareness of cancers and educational 
leaflets, only a small proportion of the GPs 
considered this activity a priority for their 
practice. Reservations about awareness 
campaigns, and sending leaflets out in 
particular, included concerns about raising 
patient anxiety, the possible pressure 
on appointments and referrals, and the 
financial impact. Some reservations 
stemmed from the need for any intervention 
to be evidence-based and there is, as yet, 
only limited published evidence that links 
raising patient awareness with earlier stage 
at diagnosis and no evidence as yet of any 
impact on mortality rates.8 GPs are best 
placed to give informed views on how to 
design and implement interventions that 
target their practice populations effectively. 
Strengths and limitations
This is the first study that gives a voice to an 
important stakeholder group in the debate 
about the benefits and costs of implementing 
individualised cancer awareness education 
within primary care.
Approaching GPs directly may be more 
effective in achieving a more representative 
sample than achieved here: this sample 
comprised mostly female responders, which 
is perhaps not surprising in a study about 
cancers affecting women. This may have led 
to an overestimation of the priority attached 
to raising awareness of gynaecological 
cancers, and it could explain the discrepancy 
between the numbers who perceived it to be 
a personal rather than a practice priority.
Health professional surveys typically have 
a low response rate,19,20 but the number of 
participants in this survey compared with the 
potential numbers contacted was possibly 
lower than similar studies.21 Despite this, 
and it not being possible to calculate an 
accurate response rate, the decision to 
contact GPs via professional organisations 
was beneficial in rapidly gaining access to a 
large number of GPs across the UK.
Comparison with existing literature
The reasons offered by GPs for why women 
with gynaecological cancer symptoms may 
present late in primary care are broadly 
similar to those previously discussed in the 
literature.22–24 Patient education was the 
most frequent suggestion for improving early 
presentation. GPs were understandably 
concerned, however, about the potential for 
a negative impact on patients. Concerns 
about raising patient anxiety as a result of 
education are not supported by evidence 
in the literature, which shows little or 
no impact on ‘current state’ anxiety in 
samples exposed to cancer awareness 
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information.25–27 GP education in relation 
to cancer awareness should include this 
information. GPs also expressed concern 
that increasing symptom awareness could 
lead to unnecessary investigations and 
associated patient distress. Evidence from 
existing gynaecological cancer literature 
comes from trials of population screening 
for ovarian cancer and suggests that when 
women receive an abnormal result which 
on subsequent testing is normalised (false 
positive) they do not report long-term 
distress.28 There is the possibility, however, 
that these false-positive results lead to 
unnecessary surgical intervention which 
has a risk of complications.29 Promoting 
symptom awareness as reported here is 
not the same as population screening; GPs 
triage patients deciding who has further 
investigations, and so, theoretically, false-
positive results and their consequences 
should be fewer, but this needs to be 
quantified through research.
In terms of cost, the increase in cost 
of more frequent investigations must be 
offset against any potential reduction in 
cancer morbidity and mortality. The potential 
economic impact of earlier diagnosis 
initiatives has been modelled for some 
cancers (including breast, colorectal, lung, 
and melanoma), leading to the conclusion 
that such initiatives would at least be cost-
effective, although not cost-saving.30 The 
intention of awareness-raising activities 
is to increase the number of symptomatic 
presentations, but GPs understandably 
expressed concern that such interventions 
could generate a large number of 
unnecessary presentations. Research that 
quantifies the likely increase in appointments 
and their outcome in terms of positive 
diagnoses is still needed. Preliminary work 
from national campaigns using the ‘Be 
Clear on Lung Cancer’ branding, suggests 
that the increase in patient consultations 
is manageable (fewer than three additional 
presentations per practice per week).31 
However, the individual-level approach 
defined in this study, with a targeted leaflet 
sent to patients on GPs’ lists, has not yet 
been assessed for its impact on patient 
behaviour. Previous studies using this 
approach have only looked at intermediate 
patient outcomes;  that is, those that 
precede behaviour, such as changes in 
beliefs or knowledge.32 Potentially, this type 
of GP-endorsed direct mailing may produce 
a more powerful behavioural response. This 
hypothesis is now being tested by distributing 
the gynaecological cancer leaflet described 
in this study to 10 pilot practices in and 
around North London.
Cancer symptoms can be non-specific 
and diagnostic delays have been linked 
to misattributions by clinicians and a 
failure to investigate symptoms that 
appear ambiguous.22,33,34 An increase in 
cancer-specific training and widespread 
implementation of decision support tools 
for GPs may increase their confidence in 
identifying patients with potential cancer 
symptoms. Significant progress has been 
made in this area recently,35,36 particularly 
in relation to the risk assessment tools 
(RATs) developed by Hamilton et al.37 (lung 
and bowel cancers), and Hippisley-Cox and 
Coupland’s ‘QCancer’ risk scores38,39 (which 
included gynaecological cancers in women), 
although how well they work in practices in 
general is not yet established. An effective 
approach could be to run public awareness 
campaigns in conjunction with GP education 
programmes. This approach was recently 
used to increase presentations to GPs 
and referrals for chest X-rays, and led to a 
27% increase in lung cancer diagnoses in 
intervention areas compared with controls, 
although this difference was not statistically 
significant.9
One important issue included in the 
current survey was access to diagnostic 
tests. Improving direct GP access to 
diagnostic tests for cancer has been an 
important part of the NAEDI strategy, with 
access to ultrasound identified as one 
of four top priorities.40 Therefore, it was 
reassuring to find that participating GPs 
generally reported good access to diagnostic 
services. Concern was still expressed, 
however, about waiting times and the 
possibility that a primary care intervention 
may exacerbate pressure on secondary care 
services. One recent report33 showed that a 
sample of GPs (n = 402) perceived significant 
improvements in access to ultrasound, but 
one in four tests was still taking >1 month. 
Greater dissemination of information on 
diagnostic service capacity limitations will 
help GPs make an informed decision about 
participation in awareness-raising activities.
Implications for research and practice
This survey shows that GPs are mainly 
supportive of projects to raise awareness 
of cancer but that they are concerned about 
the possible negative impact on patients, 
their own workload, and the availability of 
services in secondary care. There is a need 
to know more about the cost benefit of 
public cancer awareness interventions. An 
understanding of the impact on workload is 
vital if GPs are to commit time and money to 
such intervention.
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